DEA & Telehealth
DEA updates on the use of telehealth and telephone to prescribe controlled substances.
DEA updates on the use of telehealth and telephone to prescribe controlled substances.
As things rapidly develop on both what we know about COVID-19, policies around telehealth have also been developing alongside of it. This fact sheet includes a summary of what is covered by various public and private payers with the information that has been released. Keep in mind that events are evolving and to consider this a living document that could change frequently as new information and new policies become available/are enacted.
This fact sheet include changes implemented due to responses to COVID-19 that have impacted telehealth policy in California. DHCS may still be submitting another 1135 Waiver and possible 1115 Waiver to the federal government. Policy continues to develop.